BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 14973217)

  • 1. Excision margins in high-risk malignant melanoma.
    Thomas JM; Newton-Bishop J; A'Hern R; Coombes G; Timmons M; Evans J; Cook M; Theaker J; Fallowfield M; O'Neill T; Ruka W; Bliss JM; ; ;
    N Engl J Med; 2004 Feb; 350(8):757-66. PubMed ID: 14973217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.
    Cohn-Cedermark G; Rutqvist LE; Andersson R; Breivald M; Ingvar C; Johansson H; Jönsson PE; Krysander L; Lindholm C; Ringborg U
    Cancer; 2000 Oct; 89(7):1495-501. PubMed ID: 11013363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick).
    Khayat D; Rixe O; Martin G; Soubrane C; Banzet M; Bazex JA; Lauret P; Vérola O; Auclerc G; Harper P; Banzet P;
    Cancer; 2003 Apr; 97(8):1941-6. PubMed ID: 12673721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.
    Ringborg U; Andersson R; Eldh J; Glaumann B; Hafström L; Jacobsson S; Jönsson PE; Johansson H; Krysander L; Lagerlöf B
    Cancer; 1996 May; 77(9):1809-14. PubMed ID: 8646678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of melanoma-in-situ using a staged marginal and central excision technique.
    Möller MG; Pappas-Politis E; Zager JS; Santiago LA; Yu D; Prakash A; Kinal A; Clark GS; Zhu W; Puleo CA; Glass LF; Messina JL; Sondak VK; Cruse CW
    Ann Surg Oncol; 2009 Jun; 16(6):1526-36. PubMed ID: 19050971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.
    Veronesi U; Cascinelli N; Adamus J; Balch C; Bandiera D; Barchuk A; Bufalino R; Craig P; De Marsillac J; Durand JC
    N Engl J Med; 1988 May; 318(18):1159-62. PubMed ID: 3079582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm.
    Hunger RE; Angermeier S; Seyed Jafari SM; Ochsenbein A; Shafighi M
    J Am Acad Dermatol; 2015 Jun; 72(6):1054-9. PubMed ID: 25877659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas.
    Pasquali S; Haydu LE; Scolyer RA; Winstanley JB; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Thompson JF
    Ann Surg; 2013 Jul; 258(1):152-7. PubMed ID: 23426339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wide excision without radiation for desmoplastic melanoma.
    Arora A; Lowe L; Su L; Rees R; Bradford C; Cimmino VC; Chang AE; Johnson TM; Sabel MS
    Cancer; 2005 Oct; 104(7):1462-7. PubMed ID: 16080180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
    Scott JD; McKinley BP; Bishop A; Trocha SD
    Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.
    Haigh PI; DiFronzo LA; McCready DR
    Can J Surg; 2003 Dec; 46(6):419-26. PubMed ID: 14680348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
    Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
    Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives.
    Bachaud JM; Shubinski R; Boussin G; Chevreau C; David JM; Viraben R; Bonafé JL; Daly NJ
    Eur J Surg Oncol; 1992 Oct; 18(5):442-8. PubMed ID: 1426294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.
    Huilgol SC; Selva D; Chen C; Hill DC; James CL; Gramp A; Malhotra R
    Arch Dermatol; 2004 Sep; 140(9):1087-92. PubMed ID: 15381549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial.
    Gillgren P; Drzewiecki KT; Niin M; Gullestad HP; Hellborg H; Månsson-Brahme E; Ingvar C; Ringborg U
    Lancet; 2011 Nov; 378(9803):1635-42. PubMed ID: 22027547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral lentiginous melanoma: conventional histology vs. three-dimensional histology.
    Lichte V; Breuninger H; Metzler G; Haefner HM; Moehrle M
    Br J Dermatol; 2009 Mar; 160(3):591-9. PubMed ID: 19067697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 128 cases.
    Chen JY; Hruby G; Scolyer RA; Murali R; Hong A; Fitzgerald P; Pham TT; Quinn MJ; Thompson JF
    Cancer; 2008 Nov; 113(10):2770-8. PubMed ID: 18823042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.